Psychedelic-assisted psychotherapy (PAP) challenges standard models of clinical research. Treating PAP as a drug-in-context intervention, the paper proposes EBM* as a context-sensitive extension of evidence-based medicine

Lalumera, E. (2026). Drug in context. Evidence, Validity, and the Limits of EBM in Psychedelic Psychotherapy. AZIMUTH, 13(26), 79-101.

Drug in context. Evidence, Validity, and the Limits of EBM in Psychedelic Psychotherapy

Elisabetta Lalumera
Primo
2026

Abstract

Psychedelic-assisted psychotherapy (PAP) challenges standard models of clinical research. Treating PAP as a drug-in-context intervention, the paper proposes EBM* as a context-sensitive extension of evidence-based medicine
2026
Lalumera, E. (2026). Drug in context. Evidence, Validity, and the Limits of EBM in Psychedelic Psychotherapy. AZIMUTH, 13(26), 79-101.
Lalumera, Elisabetta
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1056870
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact